More Mesoblast Limited news
Mesoblast LimitedASX: MSB

Reversed Arterial Dysfunction And Inflammation in RA Model

Feb 10, 2016 at 8:19 PM EST · Issued by Mesoblast Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

On 6ix: 6ix.com/news/reversed-arterial-dysfunction-and-inflammation-in-ra-model

View Attachment

6ix hasn’t read this filing yet.

Mesoblast Limited on 6ix

Later from Mesoblast

  • Phase 3 Heart Failure Trial Size Substantially ReducedFeb 11, 2016
  • MSB Therapy Shows Benefit In First Cohort Of RA PatientsFeb 15, 2016
  • Half Yearly Report and Accounts (including Appendix 4D)Feb 16, 2016
  • Increased Survival Using MSB Cells In Children With aGVHDFeb 21, 2016
  • GVHD Product Launched In JapanFeb 24, 2016
All Mesoblast news releases↗

Follow Mesoblast into a list and get an email when it puts out news.

Follow Mesoblast
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer